3D Cardiac Differentiation

GN Gabriel Neiman
MS María Agustina Scarafía
AG Alejandro La Greca
NV Natalia L. Santín Velazque
XG Ximena Garate
AW Ariel Waisman
AM Alan M. Möbbs
TK Tais Hanae Kasai-Brunswick
FM Fernanda Mesquita
DM Daiana Martire-Greco
LM Lucía N. Moro
CL Carlos Luzzani
AC Adriana Bastos Carvalho
GS Gustavo E. Sevlever
AC Antonio Campos de Carvalho
AG Alejandra S. Guberman
SM Santiago G. Miriuka
request Request a Protocol
ask Ask a question
Favorite

In order to generate cardiac embryoid bodies (cEBs), hPSCs were incubated with 1 mg/mL of collagenase I (Sigma-Aldrich) in PBS with Ca++ and Mg++ supplemented with 20% FBS for 20 minutes at 37 °C. Afterwards, cells were detached to form small aggregates of 10 to 20 cells by 0.05% Trypsin-EDTA (Thermo Fisher Scientific) digestion and mechanical scrapping. Aggregates were plated in ultra-low attachment plates (Corning) at 37 °C and 5% CO22with the following basal culture medium: StemPro®-34 SFM (Life Technologies), 1% glutamine, 1% penicillin–streptomycin, 150 μg/mL transferrin (Roche Life Sciences), 0.039 μL/mL monothioglycerol (Sigma-Aldrich), 50 μg/mL ascorbic acid (Sigma-Aldrich). To induce differentiation, the basal culture medium was supplemented with BMP4 (Tocris), bFGF (Thermo Fisher Scientific), Activin A (Tocris), and the Wnt/B-catenin inhibitor XAV939 (Tocris). At day 15 the percentage of NKX2-5/GFP(+) cells were analyzed by flow cytometry. Again, these cardiomyocytes shows spontaneous beating activity28.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A